fda bpc-157 warning letter peptide scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR US FDA staff highlights peptide
US FDA staff highlights peptide risks, says little evidence of benefits FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the FDA's Overreach on Compounded Peptides RFK Convenes Unusual FDA Panel to Assess Peptide Safety Issues Business Insider
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

